Stockscreener 앱 받기
1.38
0.73%
0.010
시장 영업 전:
1.44
0.06
+4.35%
Mira Pharmaceuticals Inc 주식(MIRA)의 최신 뉴스
MIRA Pharmaceuticals Announces Virtual Annual Meeting to Discuss SKNY Merger - MSN
Combining price and volume data for MIRA Pharmaceuticals Inc.Short Term Profit Strategy with Entry Cues - Newser
Real time scanner hits for MIRA Pharmaceuticals Inc. explainedFree Alert Feed for Momentum Based Picks - Newser
MIRA Pharmaceuticals Inc. stock trendline breakdown3-Year Equity Summary With Setup Insights - Newser
Analyzing drawdowns of MIRA Pharmaceuticals Inc. with statistical toolsFree High Win Rate Trading Opportunities - Newser
Is it too late to sell MIRA Pharmaceuticals Inc.Pattern Breakout Prediction for Short Term - Newser
How to build a custom watchlist for MIRA Pharmaceuticals Inc.Smart Trend Analysis With Buy Point Cues - Newser
MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study - The Florida Times-Union
What makes MIRA Pharmaceuticals Inc. stock price move sharplyUncover the best stocks for explosive growth - Jammu Links News
What analysts say about MIRA Pharmaceuticals Inc. stockAchieve rapid returns with smart investment plans - Jammu Links News
When is MIRA Pharmaceuticals Inc. stock expected to show significant growthBuild a strong portfolio for long-term success - Jammu Links News
What are MIRA Pharmaceuticals Inc. company’s key revenue driversExceptional stock performance - Jammu Links News
Is MIRA Pharmaceuticals Inc. stock overvalued or undervaluedInvest confidently with daily market forecasts - Jammu Links News
Published on: 2025-08-03 20:19:04 - Jammu Links News
Is MIRA Pharmaceuticals Inc. a growth stock or a value stockAchieve exceptional returns with expert guidance - Jammu Links News
What are the latest earnings results for MIRA Pharmaceuticals Inc.Free Capital Growth Strategies - Jammu Links News
Why is MIRA Pharmaceuticals Inc. stock attracting strong analyst attentionExplosive earning power - Jammu Links News
Does MIRA Pharmaceuticals Inc. stock perform well during market downturnsHigh-return market picks - Jammu Links News
What is MIRA Pharmaceuticals Inc. company’s growth strategyFinancial News Target Finder That Work - Jammu Links News
What are the technical indicators suggesting about MIRA Pharmaceuticals Inc.Advanced Screener Report With Low Risk - Jammu Links News
MIRA Pharmaceuticals to Participate in BIO 2025 in Boston and Highlights Ongoing Progress Across Clinical Program - Sentinel-Standard
What catalysts could drive MIRA Pharmaceuticals Inc. stock higher in 2025Post Market Target Finder To Watch Now - Jammu Links News
How does MIRA Pharmaceuticals Inc. generate profit in a changing economyReal Time Planner For Fast Growth - Jammu Links News
Key External Factors That Drive MIRA Pharmaceuticals Inc. Stock Price MovementsGrowth Based Stock Signal Screener Updated - metal.it
How many analysts rate MIRA Pharmaceuticals Inc. as a “Buy”Best Dividend Report From AI Tools - Jammu Links News
Insider Sales At MIRA Pharmaceuticals Landed A Good Price - 富途牛牛
Revolutionary Topical Pain Drug Rivals Morphine in Efficacy: Major Breakthrough in $11.5B Market - Stock Titan
MIRA Pharmaceuticals Reports Promising Preclinical Results - TipRanks
Is This a Bottoming Phase for MIRA Pharmaceuticals Inc.Stock Market Entry Timing Signals Revealed - metal.it
FDA clears MIRA’s IND application for neuropathic pain drug Ketamir-2 - Investing.com Canada
FDA clears MIRA’s IND application for neuropathic pain drug Ketamir-2 By Investing.com - Investing.com South Africa
MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain - Corsicana Daily Sun
MIRA's Novel Pain Drug Shows 112% Better Relief Than Current Treatments, FDA Gives Green Light - Stock Titan
Mira Pharmaceuticals shares rise 2.91% after-hours following FDA clearance of Ketamir-2 IND. - AInvest
MIRA Pharmaceuticals Gets FDA Clearance for Ketamir-2 Trials - TipRanks
0.63%
1.44%
자본화:
|
볼륨(24시간):